Antibody-Dependent, Gamma Interferon-Independent Sterilizing Immunity Induced by a Subunit Malaria Vaccine
- PMID: 31308085
- PMCID: PMC6759290
- DOI: 10.1128/IAI.00236-19
Antibody-Dependent, Gamma Interferon-Independent Sterilizing Immunity Induced by a Subunit Malaria Vaccine
Abstract
The development of effective malaria vaccines is hampered by incomplete understanding of the immunological correlates of protective immunity. Recently, the moderate clinical efficacy of the Plasmodium falciparum circumsporozoite protein (CSP)-based RTS,S/AS01E vaccine in phase 3 studies highlighted the urgency to design and test more efficacious next-generation malaria vaccines. In this study, we report that immunization with recombinant CSP from Plasmodium yoelii (rPyCSP), when delivered in Montanide ISA 51, induced sterilizing immunity against sporozoite challenge in C57BL/6 and BALB/c strains of mice. This immunity was antibody dependent, as evidenced by the complete loss of immunity in B-cell-knockout (KO) mice and by the ability of immune sera to neutralize sporozoite infectivity in mice. Th2-type isotype IgG1 antibody levels were associated with protective immunity. The fact that immunized gamma interferon (IFN-γ)-KO mice and wild-type (WT) mice have similar levels of protective immunity and the absence of IFN-γ-producing CD4+ and CD8+ T cells in protected mice, as shown by flow cytometry, indicate that the immunity is IFN-γ independent. Protection against sporozoite challenge correlated with higher frequencies of CD4+ T cells that express interleukin-2 (IL-2), IL-4, and tumor necrosis factor alpha (TNF-α). In the RTS,S study, clinical immunity was associated with higher IgG levels and frequencies of IL-2- and TNF-α-producing CD4+ T cells. The other hallmarks of immunity in our study included an increased number of follicular B cells but a loss in follicular T helper cells. These results provide an excellent model system to evaluate the efficacy of novel adjuvants and vaccine dosage and determine the correlates of immunity in the search for superior malaria vaccine candidates.
Keywords: antibodies; malaria; protection; vaccine.
Copyright © 2019 American Society for Microbiology.
Figures





Similar articles
-
Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection.Nat Commun. 2018 Jul 13;9(1):2714. doi: 10.1038/s41467-018-05041-7. Nat Commun. 2018. PMID: 30006528 Free PMC article.
-
CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine.Infect Immun. 2004 Feb;72(2):949-57. doi: 10.1128/IAI.72.2.949-957.2004. Infect Immun. 2004. PMID: 14742540 Free PMC article.
-
A hybrid multistage protein vaccine induces protective immunity against murine malaria.Infect Immun. 2012 Apr;80(4):1491-501. doi: 10.1128/IAI.05980-11. Epub 2012 Jan 17. Infect Immun. 2012. PMID: 22252877 Free PMC article.
-
Malaria vaccine adjuvants: latest update and challenges in preclinical and clinical research.Biomed Res Int. 2013;2013:282913. doi: 10.1155/2013/282913. Epub 2013 Apr 23. Biomed Res Int. 2013. PMID: 23710439 Free PMC article. Review.
-
Induction and maintenance of protective CD8+ T cells against malaria liver stages: implications for vaccine development.Mem Inst Oswaldo Cruz. 2011 Aug;106 Suppl 1(0 1):172-8. doi: 10.1590/s0074-02762011000900022. Mem Inst Oswaldo Cruz. 2011. PMID: 21881772 Free PMC article. Review.
Cited by
-
A multivalent Plasmodium falciparum circumsporozoite protein-based nanoparticle malaria vaccine elicits a robust and durable antibody response against the junctional epitope and the major repeats.Bioeng Transl Med. 2023 Mar 28;8(4):e10514. doi: 10.1002/btm2.10514. eCollection 2023 Jul. Bioeng Transl Med. 2023. PMID: 37476056 Free PMC article.
-
Protective efficacy and correlates of immunity of immunodominant recombinant Babesia microti antigens.Infect Immun. 2023 Oct 17;91(10):e0016223. doi: 10.1128/iai.00162-23. Epub 2023 Sep 20. Infect Immun. 2023. PMID: 37728332 Free PMC article.
-
The Complexity of Interferon Signaling in Host Defense against Protozoan Parasite Infection.Pathogens. 2023 Feb 15;12(2):319. doi: 10.3390/pathogens12020319. Pathogens. 2023. PMID: 36839591 Free PMC article. Review.
-
Vesicular stomatitis virus-based vaccine targeting plasmodium blood-stage antigens elicits immune response and protects against malaria with protein booster strategy.Front Microbiol. 2022 Nov 24;13:1042414. doi: 10.3389/fmicb.2022.1042414. eCollection 2022. Front Microbiol. 2022. PMID: 36504817 Free PMC article.
-
Transdermal Immunization of Elastic Liposome-Laden Recombinant Chimeric Fusion Protein of P. falciparum (PfMSP-Fu24) Mounts Protective Immune Response.Nanomaterials (Basel). 2021 Feb 5;11(2):406. doi: 10.3390/nano11020406. Nanomaterials (Basel). 2021. PMID: 33562617 Free PMC article.
References
-
- WHO. 2018. World malaria report 2018. World Health Organization, Geneva, Switzerland: https://www.who.int/malaria/publications/world-malaria-report-2018/repor.../.
-
- Kester KE, Cummings JF, Ofori-Anyinam O, Ockenhouse CF, Krzych U, Moris P, Schwenk R, Nielsen RA, Debebe Z, Pinelis E, Juompan L, Williams J, Dowler M, Stewart VA, Wirtz RA, Dubois MC, Lievens M, Cohen J, Ballou WR, Heppner DG Jr, RTS,S Vaccine Evaluation Group. 2009. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J Infect Dis 200:337–346. doi:10.1086/600120. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials